Woodline Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Woodline Partners's AMGN Position: Q2 2026 in Review
Woodline Partners increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $11.1M and bringing the position to 238,092 shares worth $86.2M. The position accounts for 0.27% of the portfolio, ranked #88.
Woodline Partners first reported a position in AMGN in Q4 2019 and has held it in 22 quarters since. The position peaked at $115M in Q4 2020. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Woodline Partners held 238,092 shares of Amgen worth $86.2M as of Q2 2026.
- Woodline Partners bought 32,290 Amgen shares in Q2 2026, an estimated $11.1M.
- Amgen made up 0.27% of Woodline Partners's portfolio in Q2 2026, its #88 holding.
- Woodline Partners first reported a position in Amgen in Q4 2019 and has held it in 22 quarters since.
- Woodline Partners's Amgen position peaked at $115M in Q4 2020.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.